{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T18:40:38Z","timestamp":1767724838596,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd014755","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000}}],"reference-count":76,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd014755.pub2","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T11:43:23Z","timestamp":1727091803000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fertility-sparing surgical interventions for low-risk, non-metastatic gestational trophoblastic neoplasia"],"prefix":"10.1002","volume":"2024","author":[{"given":"Sathana","family":"Boonyapipat","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine; Prince of Songkla University; Songkhla Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kulisara","family":"Nanthamongkolkul","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine; Prince of Songkla University; Songkhla Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nungrutai","family":"Saeaib","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine; Prince of Songkla University; Songkhla Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tippawan","family":"Liabsuetrakul","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Faculty of Medicine; Prince of Songkla University; Songkhla Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"10.1002\/14651858.CD014755.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2147\/IJWH.S139226","article-title":"A pilot randomized controlled clinical trial of second uterine curettage versus usual care to determine the effect of re-curettage on patients\u2019 need for chemotherapy among women with low risk, nonmetastatic gestational trophoblastic neoplasm in Urmia, Iran","volume":"9","author":"Ayatollahi","year":"2017","journal-title":"International Journal of Women's Health"},{"issue":"5","key":"10.1002\/14651858.CD014755.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/AOG.0000000000003232","article-title":"Second uterine curettage and the number of chemotherapy courses in postmolar gestational trophoblastic neoplasia: a randomized controlled trial","volume":"133","author":"Hemida","year":"2019","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0003|cit3","unstructured":"Hemida R CUPT study [personal communication] Email to: S Boonyapipat"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0004|cit4","doi-asserted-by":"crossref","unstructured":"Second uterine curettage and the number of chemotherapy courses in postmolar gestational trophoblastic neoplasia: a randomized controlled trial Obstetrics & Gynecology 2019 134 3 652. Erratum for: Obstetrics & Gynecology 2019;133(5):1024 31","DOI":"10.1097\/AOG.0000000000003424"},{"issue":"11","key":"10.1002\/14651858.CD014755.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/1097-0142(196611)19:11<1517::AID-CNCR2820191109>3.0.CO;2-D","article-title":"Surgical intervention during chemotherapy of gestational trophoblastic neoplasms","volume":"19","author":"Ketcham","year":"1966","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD014755.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000268789","article-title":"Management of trophoblastic tumors using surgery and chemotherapy, alone or in combination","volume":"19","author":"Parsa","year":"1979","journal-title":"Gynakologische Rundschau"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0007|cit7","unstructured":"A prospective randomized multicenter clinical control study of hysteroscopic repeat curettage as the primal management of low-risk postmolar gestational trophoblastic neoplasia https:\/\/clinicaltrials.gov\/study\/NCT03703271"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0008|cit8","unstructured":"Impact of second uterine evacuation in women with non-metastatic, low-risk gestational trophoblastic neoplasia: a phase III trial https:\/\/clinicaltrials.gov\/study\/NCT04756713"},{"issue":"5","key":"10.1002\/14651858.CD014755.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"Journal of the National Cancer Institute"},{"issue":"12","key":"10.1002\/14651858.CD014755.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/aogs.13209","article-title":"Complications in operative hysteroscopy - is prevention possible?","volume":"96","author":"Aas-Eng","year":"2017","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD014755.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ygyno.2007.09.006","article-title":"Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens","volume":"108","author":"Abr\u00e3o","year":"2008","journal-title":"Gynecologic Oncology"},{"issue":"1","key":"10.1002\/14651858.CD014755.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5539\/jmbr.v10n1p88","article-title":"The curative effect of a second curettage in low-risk gestational trophoblastic neoplasia","volume":"10","author":"Ahmadzadeh","year":"2020","journal-title":"Journal of Molecular Biology Research"},{"issue":"1","key":"10.1002\/14651858.CD014755.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/AOG.0000000000003566","article-title":"Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization following molar pregnancy: a systematic review and meta-analysis","volume":"135","author":"Albright","year":"2020","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0014|cit14","first-page":"27","article-title":"Repeat curettage in the management of low-risk gestational trophoblastic neoplasia (GTN)","volume":"37","author":"Aminimoghaddam","year":"2023","journal-title":"Medical Journal of the Islamic Republic of Iran"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2147\/IJWH.S139226","article-title":"A pilot randomized controlled clinical trial of second uterine curettage versus usual care to determine the effect of re-curettage on patients\u2019 need for chemotherapy among women with low risk, nonmetastatic gestational trophoblastic neoplasm in Urmia, Iran","volume":"9","author":"Ayatollahi","year":"2017","journal-title":"International Journal of Women's Health"},{"issue":"3","key":"10.1002\/14651858.CD014755.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1373\u201385","DOI":"10.1002\/1097-0142(197609)38:3<1373::AID-CNCR2820380342>3.0.CO;2-E","article-title":"Risk and prognostic factors in trophoblastic neoplasia","volume":"38","author":"Bagshawe","year":"1976","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0017|cit17","unstructured":"Berkowitz RS Horowitz NS Elias KM Initial management of low-risk gestational trophoblastic neoplasia; 2021 www.uptodate.com\/contents\/initial-management-of-low-risk-gestational-trophoblastic-neoplasia"},{"issue":"5-6","key":"10.1002\/14651858.CD014755.pub2-BIB0018|cit18","first-page":"241","article-title":"Epidemiological report on the treatment of patients with gestational trophoblastic disease in 10 Brazilian referral centers. Results after 12 years since International FIGO 2000 consensus","volume":"59","author":"Braga","year":"2014","journal-title":"Journal of Reproductive Medicine"},{"issue":"6","key":"10.1002\/14651858.CD014755.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/oxfordjournals.aje.a114337","article-title":"Choriocarcinoma incidence in the United States","volume":"126","author":"Brinton","year":"1986","journal-title":"American Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD014755.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0021|cit21","unstructured":"Cooper DB Menefee GW Dilation and Curettage https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK568791\/"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0022|cit22","unstructured":"US National Cancer Institute US Department of Health and Human Services Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0; 27 November 2017 Available at ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7.pdf"},{"issue":"6","key":"10.1002\/14651858.CD014755.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/bjc.1990.434","article-title":"Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist","volume":"62","author":"De Haes","year":"1990","journal-title":"British Journal of Cancer"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0024|cit24","volume-title":"Systematic Reviews in Health Care: Meta-Analysis in Context","author":"Deeks","year":"2001"},{"issue":"1","key":"10.1002\/14651858.CD014755.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"2197292","DOI":"10.1080\/07853890.2023.2197292","article-title":"A survey on the current practice of indicating an elective cesarean after a previous myomectomy","volume":"55","author":"Delli Carpini","year":"2023","journal-title":"Annals of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD014755.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD014755.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jogc.2020.03.001","article-title":"Guideline no. 408: management of gestational trophoblastic diseases","volume":"43","author":"Eiriksson","year":"2021","journal-title":"Journal of Obstetrics and Gynaecology Canada"},{"issue":"11","key":"10.1002\/14651858.CD014755.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.6004\/jnccn.2019.7364","article-title":"State-of-the-art workup and initial management of newly diagnosed molar pregnancy and postmolar gestational trophoblastic neoplasia","volume":"17","author":"Elias","year":"2019","journal-title":"Journal of National Comprehensive Cancer Network"},{"issue":"3","key":"10.1002\/14651858.CD014755.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0020-7292(02)00063-2","article-title":"FIGO staging for gestational trophoblastic neoplasia 2000","volume":"77","author":"FIGO Oncology Committee","year":"2002","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"11","key":"10.1002\/14651858.CD014755.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1586\/14737140.2015.1088786","article-title":"Optimal management of low-risk gestational trophoblastic neoplasia","volume":"15","author":"Goldstein","year":"2015","journal-title":"Expert Review of Anticancer Therapy"},{"issue":"2","key":"10.1002\/14651858.CD014755.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/gyno.1993.1028","article-title":"Development of postmolar trophoblastic disease after partial molar pregnancy","volume":"48","author":"Goto","year":"1993","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0032|cit32","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2021"},{"issue":"2","key":"10.1002\/14651858.CD014755.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2008.11.003","article-title":"Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia","volume":"112","author":"Growdon","year":"2009","journal-title":"Gynecologic Oncology"},{"issue":"4","key":"10.1002\/14651858.CD014755.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0002-9378(73)90389-X","article-title":"Treatment of metastatic trophoblastic disease: good and poor prognosis","volume":"115","author":"Hammond","year":"1973","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0035|cit35","unstructured":"Hancock BW Seckl ML Gestational Trophoblastic Disease International Society for the Study of Trophoblastic Diseases"},{"issue":"1","key":"10.1002\/14651858.CD014755.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1186\/s12885-021-08849-7","article-title":"Direct comparisons of efficacy and safety between actinomycin-D and methotrexate in women with low-risk gestational trophoblastic neoplasia: a meta-analysis of randomized and high-quality non-randomized studies","volume":"21","author":"Hao","year":"2021","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1002\/14651858.CD014755.pub2-BIB0037|cit37","first-page":"217","article-title":"The impact of uterine re-curettage, pre-evacuation and week-one level of hCG on the number of chemotherapy courses in treatment of post molar GTN","volume":"9","author":"Hemida","year":"2011","journal-title":"Journal of Experimental Therapeutics & Oncology"},{"issue":"5","key":"10.1002\/14651858.CD014755.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/AOG.0000000000003232","article-title":"Second uterine curettage and the number of chemotherapy courses in postmolar gestational trophoblastic neoplasia: a randomized controlled trial","volume":"133","author":"Hemida","year":"2019","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0039|cit39","unstructured":"Higgins J Thomas J Chandler J Cumpston M Li T Page M Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0040|cit40","first-page":"1805","article-title":"Report of the Registration Committee for Trophoblastic Disease","volume":"34","author":"Registration Committee for Trophoblastic Disease of the Japan Society of Obstetrics and Gynaecology","year":"1982","journal-title":"Acta Obstetrica et Gynaecologica Japonica"},{"issue":"9","key":"10.1002\/14651858.CD014755.pub2-BIB0041|cit41","first-page":"e45726","article-title":"Efficacy and safety of the surgery-first approach compared to the chemotherapy-first approach for treating low-risk gestational trophoblastic neoplasia: a systematic review and meta-analysis","volume":"15","author":"Kamijo","year":"2023","journal-title":"Cureus"},{"issue":"6","key":"10.1002\/14651858.CD014755.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3109\/00016348809029858","article-title":"Clinical evaluation of focal excision of myometrial lesion for treatment of invasive hydatidiform mole","volume":"67","author":"Kanazawa","year":"1988","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD014755.pub2-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007102.pub4","article-title":"First-line chemotherapy in low-risk gestational trophoblastic neoplasia","author":"Lawrie","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD014755.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/1097-0142(196611)19:11<1517::AID-CNCR2820191109>3.0.CO;2-D","article-title":"Surgical intervention during chemotherapy of gestational trophoblastic neoplasms","volume":"19","author":"Ketcham","year":"1966","journal-title":"Cancer"},{"issue":"Suppl XXVI","key":"10.1002\/14651858.CD014755.pub2-BIB0045|cit45","first-page":"17","article-title":"The role of second dilation and curettage in trophoblastic disease and the incidence of pregnancy in the first year after diagnosis","volume":"73","author":"Lorigan","year":"1996","journal-title":"British Journal of Cancer"},{"issue":"6","key":"10.1002\/14651858.CD014755.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ajog.2010.06.073","article-title":"Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole","volume":"203","author":"Lurain","year":"2010","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD014755.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ajog.2010.06.072","article-title":"Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia","volume":"204","author":"Lurain","year":"2011","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD014755.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"A422","DOI":"10.1136\/ijgc-2022-ESGO.905","article-title":"The efficacy of second curettage in the treatment of low-risk gestational trophoblastic neoplasia: a systematic review and meta-analysis [Abstract]","volume":"32","author":"Mah","year":"2022","journal-title":"International Journal of Gynecological Cancer"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0049|cit49","unstructured":"Meheus F Atun R Ilbawi A Chapter 10: The role of health systems in addressing inequalities in access to cancer control Vaccarella S, Lortet-Tieulent J, Saracci R, et al, editors. Reducing social inequalities in cancer: evidence and priorities for research. Lyon (FR): International Agency for Research on Cancer IARC Scientific Publications"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0050|cit50","unstructured":"National Comprehensive Cancer Network Gestational trophoblastic neoplasia (version 1.2024) Available at www.nccn.org\/professionals\/physician_gls\/pdf\/gtn.pdf"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0051|cit51","unstructured":"New Zealand Gynecologic Cancer Group Gestational trophoblastic guidelines; December 2018 Available at www.health.govt.nz\/system\/files\/documents\/publications\/gtd-guidelines-2018.pdf"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0020-7292(03)90120-2","article-title":"Gestational trophoblastic neoplasia, FIGO 2000 staging and classification","volume":"83 Suppl 1","author":"Ngan","year":"2003","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"S1","key":"10.1002\/14651858.CD014755.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ijgo.13877","article-title":"Diagnosis and management of gestational trophoblastic disease: 2021 update","volume":"155","author":"Ngan","year":"2021","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD014755.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/AOG.0000000000001554","article-title":"Second curettage for low-risk nonmetastatic gestational trophoblastic neoplasia","volume":"128","author":"Osborne","year":"2016","journal-title":"Obstetrics and Gynecology"},{"issue":"24","key":"10.1002\/14651858.CD014755.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"2815\u201334","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD014755.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000268789","article-title":"Management of trophoblastic tumors using surgery and chemotherapy, alone or in combination","volume":"19","author":"Parsa","year":"1979","journal-title":"Gynakologische Rundschau"},{"issue":"3","key":"10.1002\/14651858.CD014755.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ygyno.2004.08.045","article-title":"The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease","volume":"95","author":"Pezeshki","year":"2004","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0058|cit58","unstructured":"Royal College of Obstetricians and Gynaecologists The management of gestational trophoblastic disease. Green\u2013top Guideline No. 38; September 2020 Available at https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/epdf\/10.1111\/1471-0528.16266"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0059|cit59","unstructured":"Review Manager 5 (RevMan 5) The Cochrane Collaboration 2020"},{"issue":"1","key":"10.1002\/14651858.CD014755.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ygyno.2005.07.025","article-title":"The role of repeat uterine evacuation in trophoblast disease","volume":"99","author":"Savage","year":"2005","journal-title":"Gynecologic Oncology"},{"issue":"6","key":"10.1002\/14651858.CD014755.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1465\u201370","DOI":"10.1016\/0002-9378(90)90907-O","article-title":"Diagnostic and therapeutic curettage in gestational trophoblastic disease","volume":"162","author":"Schlaerth","year":"1990","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0062|cit62","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020 Available from training.cochrane.org\/handbook"},{"issue":"5","key":"10.1002\/14651858.CD014755.pub2-BIB0063|cit63","first-page":"978","article-title":"Trends in gestational choriocarcinoma: a 27-year perspective","volume":"102","author":"Smith","year":"2003","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD014755.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/AOG.0000000000004240","article-title":"Gestational trophoblastic disease: current evaluation and management","volume":"137","author":"Soper","year":"2021","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0065|cit65","first-page":"343","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"22","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0066|cit66","first-page":"40","article-title":"Clinical epidemiology of gestational trophoblastic disease","volume":"3","author":"Strohl","year":"2014","journal-title":"Current Obstetrics & Gynaecology"},{"issue":"5","key":"10.1002\/14651858.CD014755.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"100938","DOI":"10.1016\/j.adro.2022.100938","article-title":"Nonadherence to multimodality cancer treatment guidelines in the United States","volume":"7","author":"Tchelebi","year":"2022","journal-title":"Advances in Radiation Oncology"},{"issue":"3","key":"10.1002\/14651858.CD014755.pub2-BIB0068|cit68","first-page":"e1\u201327","article-title":"Management of gestational trophoblastic disease","volume":"128","author":"Tidy","year":"2021","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD014755.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2005.06.032","article-title":"The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey","volume":"99","author":"Van Trommel","year":"2005","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD014755.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejogrb.2020.12.001","article-title":"Curative effect of second curettage for treatment of gestational trophoblastic disease - results of the Belgian registry for gestational trophoblastic disease","volume":"257","author":"Vandewal","year":"2021","journal-title":"European Journal of Obstetrics and Gynecology and Reproductive Biology"},{"issue":"2","key":"10.1002\/14651858.CD014755.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/00016340802587974","article-title":"Treatment of gestational trophoblastic neoplasia according to the FIGO 2000 staging and scoring system: a 20 years\u2019 experience","volume":"88","author":"Wang","year":"2009","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"26","key":"10.1002\/14651858.CD014755.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"43368","DOI":"10.18632\/oncotarget.14727","article-title":"Fertility-sparing uterine lesion resection for young women with gestational trophoblastic neoplasias: single institution experience","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"issue":"11-12","key":"10.1002\/14651858.CD014755.pub2-BIB0073|cit73","first-page":"566","article-title":"Clinical response to a second uterine curettage in patients with low-risk gestational trophoblastic disease: a pilot study","volume":"59","author":"Yarandi","year":"2014","journal-title":"Journal of Reproductive Medicine"},{"issue":"1","key":"10.1002\/14651858.CD014755.pub2-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/ijgo.15140","article-title":"Second curettage versus conventional chemotherapy in avoiding unnecessary chemotherapy and reducing the number of chemotherapy courses for patients with gestational trophoblastic neoplasia: a systematic review and meta-analysis","volume":"165","author":"Zhao","year":"2024","journal-title":"International Journal of Gynecology & Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD014755.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/ijgo.15235","article-title":"Response: second curettage versus conventional chemotherapy in avoiding unnecessary chemotherapy and reducing the number of chemotherapy courses for patients with gestational trophoblastic neoplasia: a systematic review and meta-analysis","volume":"164","author":"Zhao","year":"2024","journal-title":"International Journal of Gynaecology & Obstetrics"},{"issue":"10","key":"10.1002\/14651858.CD014755.pub2-BIB0076|cit76","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014755","article-title":"Fertility-sparing, surgical interventions for low-risk, non-metastatic gestational trophoblastic neoplasia","author":"Boonyapipat","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T15:17:27Z","timestamp":1767194247000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD014755.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":76,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd014755.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]}}}